Literature DB >> 3373618

Treatment of ischemia due to "steal" by arteriovenous fistula with distal artery ligation and revascularization.

H Schanzer1, M Schwartz, E Harrington, M Haimov.   

Abstract

Three cases are described of upper extremity ischemia occurring after the creation of fistulas (AVFs) (one case) and bridge AVFs (two cases) for hemodialysis access. All three cases were successfully treated with ligation of the artery immediately distal to the origin of the AVF in conjunction with a reversed saphenous vein bypass. The latter was constructed from the artery proximal to the origin of the fistula to the artery distal to the site of ligation. Preoperative and postoperative hemodynamic measurements and complete disappearance of symptoms indicated that this procedure corrected the ischemic steal phenomenon. Angioaccess function was not affected in these three cases, thereby allowing continuation of its use immediately after corrective surgery and for follow-up periods of 1 month, 6 months, and 8 years.

Entities:  

Mesh:

Year:  1988        PMID: 3373618     DOI: 10.1067/mva.1988.avs0070770

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

1.  [Standard procedures in hemodialysis shunt surgery].

Authors:  S Roth; S Schulte; T May; S Horsch
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

2.  Distal revascularization and interval ligation: a primer for the vascular and interventional radiologist.

Authors:  Sidney Regalado; Rakesh Navuluri; Eric Vikingstad
Journal:  Semin Intervent Radiol       Date:  2009-06       Impact factor: 1.513

3.  Arterial pressure gradient of upper extremity arteriovenous access steal syndrome: treatment implications.

Authors:  Thomas Reifsnyder; George J Arnaoutakis
Journal:  Vasc Endovascular Surg       Date:  2010-07-30       Impact factor: 1.089

Review 4.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

5.  Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia.

Authors:  Salvatore T Scali; Catherine K Chang; Dan Raghinaru; Michael J Daniels; Adam W Beck; Robert J Feezor; Scott A Berceli; Thomas S Huber
Journal:  J Vasc Surg       Date:  2012-12-12       Impact factor: 4.268

6.  Distal revascularisation with interval ligation (DRIL): an experience.

Authors:  M Field; J Blackwell; A Jaipersad; M Wall; M A Silva; R H Morgan; A D Pherwani
Journal:  Ann R Coll Surg Engl       Date:  2009-04-30       Impact factor: 1.891

7.  Distal revascularization and interval ligation (DRIL) procedure requires a long bypass for optimal inflow.

Authors:  David Kopriva; Donald J McCarville; Sanjay M Jacob
Journal:  Can J Surg       Date:  2014-04       Impact factor: 2.089

8.  Radiobasilic Versus Brachiobasilic Transposition on the Upper Arm to Avoid Steal Syndrome.

Authors:  Okay Guven Karaca; Ahmet Nihat Basal; Ata Niyazi Ecevit; Mehmet Kalender; Osman Tansel Darcin; Mehmet Ali Sungur
Journal:  Med Sci Monit       Date:  2015-12-29

9.  Upper limb ischemic gangrene as a complication of hemodialysis access.

Authors:  Shamir O Cawich; Emil Mohammed; Marlon Mencia; Vijay Naraynsingh
Journal:  Case Rep Vasc Med       Date:  2015-02-25

Review 10.  Minimally Invasive Limited Ligation Endoluminal-Assisted Revision (MILLER): A Review of the Available Literature and Brief Overview of Alternate Therapies in Dialysis Associated Steal Syndrome.

Authors:  William W Sheaffer; Patrick T Hangge; Anthony H Chau; Sadeer J Alzubaidi; M-Grace Knuttinen; Sailendra G Naidu; Suvranu Ganguli; Rahmi Oklu; Victor J Davila
Journal:  J Clin Med       Date:  2018-05-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.